The Patent Finder

Odyssey Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Odyssey Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Odyssey Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,989,218Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Lapsed on the fee record
Ended Aug 2, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 2, 2019USPTO record
US 7,160,691Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Term ended Oct 14, 2018 · USPTO record
Term endedTerm ended Oct 14, 2018USPTO record
US 6,294,330Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Term ended Jul 30, 2018 · USPTO record
Term endedTerm ended Jul 30, 2018USPTO record
US 6,270,964Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Term ended Feb 2, 2018 · USPTO record
Term endedTerm ended Feb 2, 2018USPTO record
US 6,428,951Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Ended no later than Feb 2, 2018 · USPTO record
Term endedEnded no later than Feb 2, 2018USPTO record
US 8,192,944Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Ended no later than Feb 2, 2018 · USPTO record
Term endedEnded no later than Feb 2, 2018USPTO record
US 6,897,017Vivo library-versus-library selection of optimized protein-protein interactions
Formerly held
Lapsed on the fee record
Ended May 24, 2017 · USPTO record
Lapsed on the fee recordEnded May 24, 2017USPTO record
US 7,855,167In vivo screening of protein-protein interactions with protein-fragment complementation assays
Formerly held
Lapsed on the fee record
Ended Dec 21, 2014 · USPTO record
Lapsed on the fee recordEnded Dec 21, 2014USPTO record
US 7,125,563Sustained release pharmaceutical preparations and methods for producing the same
Formerly held
Lapsed on the fee record
Ended Oct 24, 2010 · USPTO record
Lapsed on the fee recordEnded Oct 24, 2010USPTO record
US 5,661,142Anti-emetic composition
Term ended
Term ended no later than Aug 26, 2017 · Low confidence
Term endedTerm ended no later than Aug 26, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited